Camilla Sylvest is on the board of Danish Crown A, argenx SE and World Diabetes Foundation and EVP-Commercial Strategy & Corporate Affairs at Novo Nordisk An and Senior Vice President & General Manager-Germany at Novo Nordisk Pharma GmbH.
She received an MBA from Scandinavian International Management Institute and a graduate degree from the University of Southern Denmark.
|